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Abstract 
This study was carried out to evaluate the effects of ethanolic leaf extract of Gongronema latifolium (Family: 
Asclepiadaceae) on blood glucose and cholesterol levels in alloxan-induced diabetic albino wistar rats. 30 male 
albino wistar rats were randomized into 4 groups (A-D). Groups A and B had 10 animals each while Groups C 
and D had 5 each. They were fed with standard feed and water ad libitum. Diabetes was induced in Groups A 
and B animals with 150mg of alloxan/kg body weight of animal. Group A rats were orally administered 400mg 
of the extract/kg body weight of animal twice daily. Group C rats also received 400mg of extract/kg body weight 
of animal for the same duration. Groups B and D animals served as diabetic and normal control respectively and 
were given distilled water in place of the extract. Treatment lasted for 10 consecutive days and blood samples for 
analysis were collected from the tail tips of the animals every two days. Results obtained showed that there were 
significant (p < 0.05) reductions in blood glucose and cholesterol levels in Group A rats post-treatment when 
compared with rats in Group B (diabetic control). No hypoglycaemic effect was observed in normal rats 
administered with the extract (p ˃ 0.05) when compared with the control animals. Therefore, the ethanolic leaf 
extract of G.latifolium has the potentials of lowering blood glucose and cholesterol levels in alloxan–induced 
diabetes and could be useful in the management of diabetes and its associated complications. 
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Introduction 
Diabetes is a metabolic disorder of multiple aetiology, characterized by chronic hyperglycaemia with 
disturbances of carbohydrates, fat and protein metabolism owing to overproduction and / or underutilization of 
glucose (1). Diabetes is the most common endocrine disorder that impairs glucose homeostasis resulting in 
severe complications including retinopathy, angiopathy, nephropathy and neuropathy (2). The disease could 
either be as a result of insufficient production of the hormone, insulin, owing to the destruction of beta cells of 
the islet of Langarhans (in which case it is referred to as Insulin Dependent Diabetes Mellitus/ Type I diabetes) 
or as a result of the cells’ inability to recognize insulin, owing to possible defective insulin receptors (in which 
case it is referred to as Non-Insulin Dependent Diabetes Mellitus/ Type II diabetes). Alloxan (2,4,5,6-
tetraoxypyrimidine 5, 6 -dioxyuracil), an oxygenated pyrimidine derivative is a toxic glucose analogue, which 
selectively destroys insulin producing beta cells in the pancreas when administered to rodents and many other 
animal species (3). Alloxan is administered parenterally: intravenously, intraperitoneally or subcutaneously, 
while the dose necessary to induce diabetes is a function of the animal species, nutritional status and route of 
administration. This diabetogenic agent causes an insulin-dependent diabetes mellitus with characteristics similar 
to type I diabetes in humans (4, 5). It has been employed in experimental models for the study of diabetes.  
Plants are sources of potential therapeutic agents against various diseases due to their biodiversity and 
the presence of a wide array of bioactive phytochemicals and secondary metabolites (6). The beneficial uses of 
medicinal plants in traditional system of medicine of many cultures are extensively documented. Several plants 
have been used as dietary adjuvant and in treating the number of diseases even without any knowledge of their 
proper functions and constituents. This practice may be attributed to the high cost and side effects of synthetic 
hypoglycemic agents (7). Plants with medicinal properties are enormously used in treating diabetes throughout 
the world. Many recent scientific investigations have also confirmed the efficacy of plant preparations, few of 
which are remarkably effective (8).  
According to an estimate, 80% of the world's population depend on plants for their medication. The 
use of the medicinal plants is increasing in many countries where 35% of drugs contain natural products and 
ethno botanical information indicates that plant species are used in the traditional management of diabetes (9, 10, 
11). Several investigations into the chemical and biological activities of plants have yielded compounds with 
properties useful for the development of modern synthetic drugs for management of several diseases including 
diabetes (12). In fact, there has been increasing demand for the use of plant products with antidiabetic activity 
due to low cost, easy accessibility and lesser side effects (13). Gongronema latifolium is a leafy vegetable of the 
family, Asclepiadaceae widely employed in Nigeria for various medicinal and nutritional purposes (14). In 
Nigeria, it is known by the Igbos as Utazi, the Efik/ Ibibio call it Utasi while the Yorubas call it Arokeke (15). 
Nutritionally, G.latifolium is a good source of protein, minerals and vitamins. Previous researches have shown 
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that the leaves are suitable for use in food production due to their high amino acid contents (16). The leaves can 
be eaten fresh, dried and used as local powdery spice or as vegetable for food preparations such as unripe 
plantain porridge, white soup, sauces and salads in which they add a bitter-sweet flavor (17). Scientific studies 
have established the cardio-protective, anti-inflammatory and antioxidative effects of aqueous and ethanolic 
extracts of G.latifolium leaf (18, 19). This study evaluates the antidiabetic effects of G.latifolium in alloxan–
induced diabetic rats. 
 
Materials and Methods 
Plant Materials 
Fresh leaves of Gongronema latifolium were harvested from a bush in Umuozu in Nwangele Local Government 
Area, Imo State, Nigeria, during the month of June. The leaves were authenticated at the Department of Plant 
Biology and Biotechnology of the University of Benin, Benin City, Nigeria. 
Preparation of Ethanolic Extracts 
The leaves of Gongronema latifolium were washed, air dried at room temperature and pulverized into powder. 
500 grams of the powder was extracted with 5 litres of absolute ethanol (BDH, England) with repeated stirring 
for 72h. The mixture was first filtered using cheese cloth and later with Whatman filter paper No. 1. The 
recovered filtrate was concentrated at 60ºC using a rotary evaporator (Buchi Labortechnik, Flawil, Switzerland) 
and the yield determined.  Five (5) grams of the extract was dissolved in 100ml of distilled water to form the 
extract stock solution from which estimated doses were administered. The doses of the extract administered was 
estimated using the method described by Tedong et al. (20).  
Experimental Animals 
Thirty (30) male albino wistar rats weighing between 100-150g were used for the study. The animals were 
housed in clean disinfected galvanized cages in the animal house (Department of Biochemistry, University of 
Benin) and maintained under a 12h light and dark cycle. They were allowed to feed (standard pelletized growers 
feed from Bendel Feed and Flower Mill, Ewu, Edo State) ad libitum and given water throughout the duration of 
the study.  
Induction of Diabetes 
Diabetes was induced in the rats by a single intraperitoneal injection of freshly prepared alloxan (Aldrich, 
Germany) solution of 150mg of alloxan/ kg body weight of animal. The rats were allowed to adapt for 48h 
before fasting blood sugar was determined using a glucometer (Accu–Check, Mannheim, Germany). Only 
animals having blood glucose levels ≥ 200 mg/dl were selected for the study. 
Experimental Design 
The experimental animals were randomized into four groups (A to D). Groups A and C had 10 animals each, 
while Groups C and D had 5 each.  
Group A was injected with 150 mg alloxan/kg body weight of animal and treated with 400 mg of G. latifolium 
extract /kg body weight animal twice daily using a gavage. 
Group B which served as positive control was injected with 150 mg alloxan/kg body weight of animal and given 
distilled water. 
Group C received by means of a gavage 400 mg of G.latifolium extract /kg body weight animal twice daily. 
Group D which served as negative control was given distilled water. 
A period of two weeks was allowed for acclimatization of animals, after which they were fasted overnight (14h) 
and blood collected from the tail tips of each animal for the estimation of baseline parameters for glucose and 
cholesterol (Pre-Alloxan), followed by the induction of diabetes in some of the animals. 
Administration of Extracts 
After the 48h adaptation period, following alloxan administration, animals were fasted overnight (14h) and blood 
samples collected (Post-Alloxan). The extract was then administered orally with the aid of a gavage, for 10 
consecutive days at a dose of 400 mg/kg body weight twice daily. Blood samples were collected (Post–
Treatment) at intervals of 2 days thereafter. 
Sample Collection 
Whole blood was collected from the tail tips of each animal into clean plain bottles every two days, until the last 
doses of extracts were administered. The blood was allowed to stand on ice for about 15 min and centrifuged (B. 
Bran Scientific, 80-2, England) at 10,000 r.p.m. for 5min. Serum was separated from the clot with Pasteur 
pipette into sterile sample tubes for biochemical assays. 
Biochemical Assays 
The blood glucose level was estimated using One Touch Glucometer (Accu–Check, Mannheim, Germany). 
Serum Cholesterol concentration was determined spectrophotometrically after enzymic hydrolysis and oxidation 
as described in the Randox reagent kit (Randox Laboratory Ltd, UK). 10µl of sample, standard and distilled 
water (which served as reagent blank) were dispensed into 3 different test tubes, and 1000 µl working reagent (4 
– aminoantipyrine) was added to each of the tubes. The mixture was allowed to stand for 10minutes at 25˚C. 
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Absorbance of the sample and of the standard were measured against the reagent blank at 500nm within 
60minutes. The indicator quinoneimine is formed hydrogen peroxide and 4 – aminoantipyrine in the presence of 
phenol and peroxidase. 
 
Statistical Analysis 
Data are expressed as mean ± standard error of mean. Significance of difference was tested by ANOVA and 
Duncan’s multiple comparison test, using SPSS Advanced Statistics Version 21.0. Statistical significance was 
set at p ≤ 0.05. 
 
Results and Discussion 
Tables 1 and 2 shows the mean values of fasting blood glucose and cholesterol of controls, normal and diabetic 
treated animals. The results revealed significant (p < 0.05) increases in levels of blood glucose and cholesterol in 
the rats administered alloxan (Groups A and B) when compared with the normal control rats (Group D). Alloxan, 
a derivative of uric acid and other substances of different chemical origin, is a diabetogenic drug (in the same 
class with streptozotocin, ditizona, etc.) which selectively degranulate and consequently degenerate the ß-cells of 
islet of Langerhans through a process mediated by reactive oxygen species ROS (21). It has been effectively 
used to induce diabetes in animal experimentation (3, 4), thus, corroborating the approach used in this study.  
A major index of assessment of diabetes mellitus is persistent hyperglycemia with its attendant effect on 
cardiovascular diseases, thus leading to an increase in cholesterol especially LDL-cholesterol “bad” fat (22). No 
significant differences were seen in blood glucose and cholesterol concentrations of the treated normal rats 
compared with their controls. A similar finding was reported by Nimenibo-Uadia and Osagie (23) with Ficus 
exasperata leaf extract which decreased blood glucose concentration in alloxan-induced diabetic rats but not in 
the normal treated rats. However, there were significant (p < 0.05) reductions in blood glucose and cholesterol 
levels in animals injected with alloxan and administered the extract of G.latifolium (Group A) when compared 
with animals injected with alloxan but not administered the extracts (Group B). This indicates anti-
hyperglycaemic and anti-hypercholesterolaemic effects for the extract.  
 
Conclusion 
This study has demonstrated that ethanolic leaf extract of G.latifolium exhibited significant (p < 0.05) 
antihyperglycaemic and antihypercholesterolaemic effects in alloxan-induced diabetic rats. Thus, suggesting a 
possible ameliorative effect and confirming its usage as a herbal remedy in the management of diabetes mellitus, 
and its associated complications.  Several authors have reported that some secondary metabolites, such as 
saponins, flavonoids, phenolic compounds and triterpenoids possess hypoglycaemic and hypolipidaemic activity 
(24, 25). Hence the observed decreases in blood glucose and cholesterol in the diabetic rats treated with 
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Table 1: Effect of ethanolic leaf extract of G. latifolium on levels of Blood Glucose in diabetic and non-
diabetic male rats (mg/dl). 
 
Data represent mean ± SEM; n = number of rats. Values with different superscripts along the same column, are 
significantly different (p ≤ 0.05). 
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Table 2: Effect of ethanolic leaf extract of G. latifolium on levels of Serum Cholesterol in diabetic and non-
diabetic male rats (mg/dl). 
 
Data represent mean ± SEM; n = number of rats. Values with different superscripts along the same column, are 
significantly different (p ≤ 0.05). 
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